Michael Pulsipher, MD
University of Utah · Children's Hospital Los Angeles · Primary Children's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michael Pulsipher, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:08 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05600426 · A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)Boston Children's Hospital · terminated · Severe Aplastic Anemia · principal investigator
- Ph2NCT03619551 · Conditioning SCID Infants Diagnosed EarlyCenter for International Blood and Marrow Transplant Research · active not recruiting · SCID · study chair
- Ph1/Ph2NCT03475212 · Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell TransplantationPediatric Transplantation & Cellular Therapy Consortium · active not recruiting · Cytomegalovirus Infections, Adenovirus Infection, EBV Infection · study chair
- N/ANCT02845596 · Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic AnemiaMichael Pulsipher · completed · Severe Aplastic Anemia · study chair
- Ph2NCT02646839 · KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT ChildrenMichael Pulsipher · enrolling by invitation · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndromes · principal investigator
- Ph2NCT00795132 · Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic MalignanciesUniversity of Utah · completed · Acute Leukaemia, Chronic Disease, Leukemia · principal investigator
- Ph2NCT00795886 · Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)University of Utah · completed · Acute Lymphoblastic Leukemia · principal investigator
- Ph3NCT00382109 · Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete RemissionChildren's Oncology Group · completed · B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:08 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic AnemiaUG3HL157564 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI Michael A Pulsipher, DAVID A WILLIAMS · fiscal years 2022Named on NCT05600426
- 1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic AnemiaU24HL157560 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Bronwen Shaw · fiscal years 2022 to 2025Named on NCT05600426
- Children's Oncology Group Chair's GrantU10CA098543 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI PETER C. ADAMSON · fiscal years 2003 to 2013Named on NCT00382109
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.